+ T H 17 cells are a proinflammatory CD4 + T-cell population associated with autoimmune tissue injury. In mice, priming of T H 17 requires TGF-β, which alone directs the priming of FOXP3 
+ effector T cells producing the proinflammatory cytokine IL-17A (hereafter IL-17), leading to chemokine production and recruitment of neutrophils to inflamed tissues (1). In mice, T H 17 cells have been shown to be involved in the pathogenesis of experimental autoimmune diseases previously attributed to unchecked T H 1 responses (1) (2) (3) (4) . In addition, assessment of patients with autoimmune diseases has suggested an involvement of T H 17 cells in some human autoimmune disorders (5, 6) . In humans, CD4 + T cells producing IL-17 ex vivo can be detected in circulating lymphocytes from healthy individuals, among memory CD4 + T cells, mainly in the CCR6 + fraction (6, 7) and contain two subpopulations cosecreting or not cosecreting IFN-γ. Both in mice and in humans, the retinoid-related orphan nuclear receptor RORγt has been identified as a lineage-specific transcription factor for T H 17 cells (6) (7) (8) .
In mice, differentiation of T H 17 cells has been shown to take place in the presence of TFG-β and IL-6 (9), with IL-23 and IL-21 amplifying their expansion and/or stabilizing their phenotype (10-12). Differentiation of human T H 17 cells from naive precursors, however, has proved difficult to achieve (13) , and several discrepant findings have been reported. Differentiation has been initially reported to require IL-1β and IL-6, and to be inhibited by TFG-β and IL-2 (14) . Subsequent studies, however, have shown TGF-β and IL-2 to be instead required (15, 16 (17) . Another study however, has suggested that several inflammatory cytokines including IL-1β, IL-6 and IL-23 are all required and act synergistically (18) .
Overall, these discrepancies have been attributed to the difficulty to ensure a truly naive population of human CD4 + T cells (19) . Finally, a recent study has proposed that human T H 17 cells originate from CD161 + precursors present in thymus and cord blood but not in peripheral blood from adult individuals (20 + Treg in the presence of LPS-activated monocytes and IL-2 converts them into T H 17 cells (22) and have recently identified a subpopulation of memory Treg that coexpress RORγt and secrete high levels of IL-17 ex vivo (24) . Together, these findings suggested that human T H 17 cells could preferentially originate from NTreg rather than from conventional naive CD4 + T-cell precursors. In this study, we show that differentiation of T H 17 cells from human circulating naive CD4 + T cells is indeed predominantly obtained from NTreg, and optimally occurs following stimulation in the presence of IL-2 and of lineage-specific differentiation factors.
Results
Priming of IL-17-Producing Cells from Adult Naive Circulating CD4 + T Cells Predominantly Occurs from NTreg. We initially stimulated total naive CD45RA + CD4 + T cells isolated from circulating lymphocytes of adult subjects with anti-CD2/CD3/CD28-coated microbeads in the presence of several previously described T H 17 polarizing cytokines, in various combinations. Under these conditions, we observed very low proportions (generally <1%) of cells secreting IL-17A (IL-17 hereafter, unless otherwise specified). To assess whether T H 17 cells could specifically differentiate from NTreg (which represent ∼5% of total naive circulating 
CD4
+ T cells), we purified naive conventional (CD45RA + CD25 − CD127 high ) and NTreg (CD45RA + CD25 + CD127 low ) populations by flow cytometry cell sorting (Fig. 1A) . Staining of the sorted populations with FOXP3-specific mAb confirmed the isolation of highly pure conventional (FOXP3 − ) and regulatory (FOXP3 + ) populations (Fig. 1A) . We stimulated the sorted populations with anti-CD2/CD3/CD28-coated microbeads in the presence of IL-2 alone or with TGF-β, IL-1β, IL-23, IL-6, or IL-21, separately or in various combinations and, 12 d later, assessed the proportion of IL-17-secreting cells in the cultures by intracellular staining. Whereas stimulation of conventional naive CD4 + T cells under these various conditions resulted in the induction of very low proportions of IL-17-producing cells, stimulation of NTreg with some of the cytokine combinations resulted in the induction of a significant fraction of IL-17-producing cells ( Fig. 1 B and C) . In particular, we obtained optimal induction in the presence of IL-2, IL-1β, IL-23, and TGF-β. Low proportions of IL-17-producing cells were induced from NTreg in the absence of IL-2, even in the presence of the most effective cytokine combination. Thus, priming of T H 17 cells from adult circulating naive CD4 + T cells consistently occurred, and predominantly took place from NTreg in the presence of IL-2 and of lineage specific polarizing factors.
Expression of IL-1RI Is Selectively Up-Regulated in NTreg Following
Stimulation and Is Increased by TGF-β. Whereas IL-23 was not active alone but increased the differentiation of T H 17 cells from NTreg in the presence of IL-1β, the latter was indispensable for differentiation to occur. To gain further insight into the differential role of these cytokines during T H 17 polarization from NTreg, we assessed the expression of their specific receptors in conventional naive CD4 + T cells and NTreg. We detected no significant expression of IL-1RI ex vivo in naive CD4 + T cells, either conventional or Treg ( Express RORγt. Expression of lineage-specific transcription factors supports the differentiation of distinct T-cell subsets by shaping their phenotypic and functional profiles. It has been proposed that the balance between the T H 17 lineage specific transcription factor RORγt, the expression of which is indispensable for IL-17 secretion, and the Treg-specific transcription factor FOXP3, which antagonizes RORγt activity, affects T H 17 cell polarization. To follow the expression of FOXP3 and RORγt during T H 17 priming from NTreg, we assessed cultures stimulated under nonpolarizing or polarizing conditions using RORγt, FOXP3, and IL-17-specific antibodies. Expression of FOXP3 in NTreg was maintained in a substantial proportion of cells after differentiation in all conditions (Fig. 3A) . The large majority of IL-17-secreting cells derived from polarized NTreg (particularly in the absence of TGF-β), however, had lost or highly decreased FOXP3 expression (Fig. 3 B and C) . Expression of RORγt, undetectable in naive CD4 + T cells ex vivo (24) , was induced in a low proportion of conventional naive CD4 + T cells and NTreg after stimulation in the presence of IL-2 with or without inflammatory cytokines or with TGF-β alone. Following stimulation with IL-2 and inflammatory cytokines together with TGF-β, however, expression of RORγt was induced in more than Results for all conditions and donors are shown in C (mean ± SD, n = 6). Statistical analyses were performed using two-tailed t test. *P < 0.05; **P < 0.01; ***P < 0.001. half of total conventional naive and NTreg populations (Fig. 3A) . Regardless of the total proportion of RORγt-expressing cells in the cultures, the large majority of IL-17-secreting cells expressed high levels of RORγt ( Fig. 3 B and C) . Thus, T H 17 cells differentiating from NTreg were FOXP3 − or FOXP3 low and expressed high levels of RORγt. + Expressing Cells. Expression of the chemokine receptor CCR6 has been described as associated with the T H 17 lineage but also to the Treg lineage (6, 7, 27, 28) . Expression of CCR6 in naive CD4 + T cells (both conventional and NTreg) was undetectable ex vivo (24) . However, CCR6 expression was induced in a small fraction of NTreg, but not in conventional naive CD4 + T cells, following stimulation in the presence of IL-2 with or without IL-1β and IL-23 (Fig. 5A) . In contrast, the presence of TFG-β slightly inhibited expression of CCR6. A recent study has shown that expression of IL-1RI in in vitro cultured human memory Treg specifically identified populations of cells that have maintained suppressor functions (29) . To clarify the relationship between expression of IL-1RI and CCR6, we costained polarized NTreg cultures with the corresponding specific mAb. This analysis identified several distinct populations (Fig. 6A) . Namely, whereas a subpopulation expressing IL-1RI but not CCR6 was clearly identified, the CCR6-expressing population included both IL-1RI − and, to a lesser extent, IL-1RI + cells. To further evaluate these subpopulations, we isolated them by cell sorting, stimulated them with PMA/ionomycin, and assessed FOXP3 expression and IL-17 production. In addition, we also assessed the capacity of the isolated populations to suppress the proliferation of responder CFSE-labeled CD4 + T cells in a functional suppression assay as described previously (21) . As illustrated in Fig. 6B 
CCR6
+ failed to inhibit the growth of responder cells (Fig. 6 C and D) . In conclusion, our analysis identified two distinct subpopulations of CCR6 + IL-17-secreting cells: one subpopulation, less abundant, expressed IL-1RI and maintained FOXP3 expression and suppressive functions, whereas the prominent subpopulation was IL-1RI − and had lost FOXP3 expression and suppressive functions.
Discussion
In this study, we have unambiguously shown that priming of human T H 17 cells consistently takes place from adult naive circulating CD4 + T cells and occurs mainly from NTreg rather than (30) . The exact underlying mechanism, however, has not been elucidated; and it has been suggested that IL-2, through binding of STAT5 to the IL-17 promoter, might attenuate IL-17 production in differentiated T H 17 cells rather than inhibiting T H 17 differentiation (16) . In line with this hypothesis, it was later shown that IL-2 is instead required for in vitro differentiation of human T H 17 cells (15) .
Similarly, in our system, the presence of IL-2 highly increased differentiation of T H 17 cells from NTreg in all conditions. TGF-β is crucial for maintenance of Treg in the periphery, although it may be dispensable for their generation in the thymus (31) . TGF-β was initially reported to inhibit the in vitro differentiation of human T H 17 cells (14), but was proved later as required (15, 16) . In this study, the presence of TGF-β was not indispensable, but increased the proportion of T H 17 cells differentiating from NTreg. It is noteworthy that NTreg express endogenous TGF-β (21), which likely has an impact on their differentiation into T H 17 cells even in the absence of exogenous sources.
We and others have recently shown that TCR stimulation in the presence of IL-1β (or IL-1α) and IL-2 or IL-15 induces the conversion of human memory Treg into T H 17 cells (22, 23) . In this study, IL-1β was indispensable for NTreg differentiation into T H 17 cells. IL-1β signals through receptor type I (IL-1RI), homologous to Toll, the conserved region being the Toll/IL-1 receptor (TIR) domain, which defines the IL-1R/TLR superfamily (32) . Interestingly, at odds with previous findings suggesting a marginal role of IL-1β in the differentiation of murine T H 17 cells in vitro, IL-1RI has recently been shown to be necessary for early differentiation of murine T H 17 cells in vivo (33) . We found selective expression of IL-1R1 in stimulated NTreg in good agreement with their increased proficiency, with respect to conventional naive CD4 + T-cell precursors, to differentiate into T H 17 cells. Interestingly, IL-1RI expression in NTreg was not affected by IL-1β or IL-23 but was significantly enhanced by TGF-β. Consistent with the role of TGF-β in inducing IL-1RI expression, the latter correlated with that of FOXP3 and identified suppressive populations in the cultures.
IL-23 is a heterodimeric cytokine composed of a p40 chain, common to IL-12, disulfide-linked to a specific p19 chain (34, 35) . Studies using p19 −/− murine models of autoimmunity identified IL-23 as the major factor involved in the induction of T H 17 cells in vivo (36) (37) (38) . However, researchers have subsequently failed to demonstrate efficient induction of T H 17 cells from naive CD4 + T cells by IL-23 in vitro (39, 40) , and have concluded that the role of IL-23 was not to induce but rather to stabilize the T H 17 phenotype. In line with this hypothesis, in this study, IL-23 alone was not able to differentiate NTreg into T H 17 cells but synergized with other polarizing factors.
T H 17 cells derived from NTreg exhibited a cytokine secretion pattern similar to those described thus far for human T H 17 populations, as they contained both cells cosecreting IL-17 and IFN-γ (double-secreting) and cells secreting IL-17 in the absence of IFN-γ secretion (single-secreting) (6) . Interestingly, whereas double-secreting cells were prevalent following polarization in the absence of TGF-β, polarization in the presence of TGF-β prevalently induced single-secreting cells. This suggests that both single-and double-secreting T H 17 cells can originate from NTreg depending on the in vivo differentiation conditions. All IL-17-secreting cells derived from NTreg cosecreted TNF-α, also highly proinflammatory. Some of them cosecreted IL-21 and IL-22, two cytokines that have been described as T H 17 associated, although not exclusively secreted by T H 17 cells (41) (42) (43) (44) . IL-17F is a proinflammatory cytokine with functions initially reported as similar to those of IL-17A and sharing the same receptor (45) . Recent studies have revealed that IL-17A and IL-17F can be expressed as homo-or heterodimers that may bind IL-17 receptors with various affinities and may play not completely redundant functions (26, 46, 47) . We found expression of IL-17F in only a fraction of IL-17A-secreting cells from NTreg, indicating the existence of distinct subpopulations that differentially express these cytokines and may be functionally distinct, an observation that warrants further investigation. Differentiation of T H 17 cells from NTreg was accompanied by induction of RORγt expression, down-regulation of FOXP3 expression and acquisition of IL-2 secretion, particularly in the IL-17-secreting fraction, suggesting that NTreg-derived T H 17 cells may have mostly lost their suppressor functions and may have instead acquired auxiliary functions. Expression of CCR6 has been reported as associated with the T H 17 but also with the Treg lineage (6, 7, 27, 28) . We found increased expression of CCR6 in stimulated NTreg as compared with conventional naive CD4 + T cells. In addition, by isolating CCR6-expressing cells from polarized cultures, we demonstrated that most IL-17-secreting cells in NTreg-derived T H 17 cell populations were contained in the CCR6 + fraction. Interestingly, assessment of CCR6 expression in relation to that of IL-1RI revealed the existence of two distinct subpopulations of CCR6 + IL-17-secreting cells: the first, less abundant, coexpressed IL-1RI and FOXP3 and retained suppressive functions, whereas the most prominent one was IL-1RI − and FOXP3
− and had lost the capacity to suppress. The identification of these subpopulations is in line with our recent finding that human IL-17 secreting cells in human peripheral blood (that are all memory cells) include a population of cells that coexpress FOXP3 and exert suppressor functions (24) . Overall, the findings reported here strongly suggest that at least part of human T H 17 cells may differentiate in vivo from NTreg precursors in the presence of lineage-specific differentiation factors. NTreg are generated in the thymus as a distinct lineage of CD4 + T cells that are anergic but are specific for self-antigens, and therefore potentially auto-reactive if stimulated under conditions that break their anergy (48). The finding that T H 17 cells mainly differentiate from NTreg therefore raises the possibility that some auto-reactive effectors in autoimmune pathologies associated with T H 17 might be generated through this differentiation pathway. Because some tumor-associated antigens are nonmutated selfantigens also expressed in cells of normal tissues that undergo malignant transformation (e.g., melanocyte differentiation antigens), differentiation of NTreg specific for these antigens into T H 17 would result in the generation of anti-tumor effectors. Interestingly, recent data have indeed shown a particular efficacy of T H 17 effectors in anti-tumor responses (49) . A preferential differentiation of T H 17 cells from NTreg, however, does not imply that all T H 17 effectors are specific for self-antigens or autoreactive. First, because part of Treg in adults could also be generated in the periphery through conversion of conventional CD4 + T cells (50) , some NTreg could represent an intermediate differentiation stage along a differentiation pathway leading from nonautoreactive, naive, conventional CD4 + T cells to memory T H 17 cells. In addition, some T H 17 cells could be generated in the periphery through conversion of induced MTreg, differentiated from CD4 + CD25 − FOXP3 − T cells, under inflammatory conditions (22, 23) .
Although the involvement of T H 17 cells in autoimmune pathology has been strongly suggested by studies in mice and in humans, little information is available on the antigens that they recognize (7) , and their potential self-reactivity has not been thus far investigated. Based on the knowledge that T H 17 cells can derive from precursors common to autoreactive Treg, insights into their antigen specificity, including reactivity to self-antigens, in human T H 17-associated pathologies, will undoubtedly contribute to clarify their role in inflammation-induced tissue damage.
Materials and Methods
Samples, Cell Purification, and ex Vivo Cell Sorting. Peripheral blood samples were obtained from the Etablissement Français du Sang (Nantes, France) upon informed consent and approval by institutional review board. Naive conventional CD4 + T cells and NTreg were isolated by flow cytometry cell sorting, as previously described (24) and detailed in SI Materials and Methods.
In Vitro Differentiation of CD4 + T-cell Populations and Phenotypic Assessment and Flow Cytometry Cell Sorting of Differentiated Cultures. Ex vivo sorted N and NTreg (3 × 10 4 ) were stimulated with anti-CD2/CD3/CD28-coated microbeads (Miltenyi Biotec) in the absence or presence of IL-1β (10 ng/mL, R&D Systems), IL-6 (50 ng/mL, R&D Systems), IL-21 (50 ng/mL, R&D systems), IL-23 (100 ng/mL, R&D Systems), and TGF-β (10 ng/mL, PeproTech) alone or in combination, as specified. Cells were maintained in culture in complete IMDM (Invitrogen) in the absence or presence of IL-2 (100 IU/mL, Chiron), as indicated. Day 5 or 12 cultures were stained with IL-RI-, IL-23R-and/or CCR6-specific antibodies and were analyzed and/or sorted by flow cytometry, as detailed in SI Materials and Methods. 
